Kanoria Chemicals & Industries Ltd (KANORICHEM) AI Stock Analysis

2 Followers

Kanoria Chemicals & Industries Ltd

(NSE:KANORICHEM)

Select Model

Rating:60Neutral

Price Target:INR 197.00▲(14.24% Upside)

Action:reiterated

Date:09/11/26

The score reflects a company in the early stages of financial recovery: profitability has returned and leverage is now materially lower, but revenues have contracted sharply and free‑cash‑flow remains weak and negative, limiting financial flexibility. Strong technicals, with the price well above key moving averages and solid momentum, support the rating yet are tempered by stretched indicator levels that raise near‑term risk. A moderate earnings valuation provides some balance, suggesting investors are not overpaying for current profits but that sustained improvement in cash generation and earnings consistency is still required for a higher score.

Positive Factors

Lower LeverageMeaningful debt reduction improves financial flexibility and can lower the burden of future interest and refinancing needs. With substantial equity relative to assets, the company is better positioned to withstand operating volatility and direct resources toward stabilizing its chemicals business.

Negative Factors

Sharp Revenue DeclineThe sharp 2026 revenue contraction signals pressure on demand, pricing, or both within the company’s industrial chemicals markets. Lower sales reduce operating leverage and make it harder to sustain margins, absorb fixed costs, or build a dependable earnings base.

Kanoria Chemicals & Industries Ltd (KANORICHEM) vs. iShares MSCI India ETF (INDA)

Market Cap: INR 7.40B
Dividend Yield: ―
Average Volume (3M): 7,511
Price to Earnings (P/E): 13.1
Beta (1Y): 0.98
Revenue Growth: -22.78%
EPS Growth: ―
Country: India
Employees: 385
Sector: General
Sector Strength: 55
Industry: Chemicals

Kanoria Chemicals & Industries Ltd Business Overview & Revenue Model

Company Description

Kanoria Chemicals & Industries Limited (KCIL), an Indian enterprise established in 1960 and based in New Delhi, specializes in the production and distribution of chemical intermediates. Operating primarily through its Alco Chemicals and Solar Power d...

How the Company Makes Money

Kanoria Chemicals & Industries Ltd primarily makes money by manufacturing and selling industrial chemicals. The company’s key revenue stream is the sale of chlor-alkali products—most notably caustic soda—along with co-products such as chlorine and al...

Kanoria Chemicals & Industries Ltd Financial Statement Overview

Summary

Return to profitability in 2026 on improved earnings but with a roughly one‑third drop in revenue, thin and volatile margins, and persistent free‑cash‑flow deficits, partially offset by a materially deleveraged, moderate‑to‑solid balance sheet.

Income Statement

42Neutral

Balance Sheet

63Positive

Cash Flow

35Negative

Financial statement breakdown
Breakdown	TTM	Mar 2026	Mar 2025	Mar 2024	Mar 2023	Mar 2022
Income Statement
Total Revenue	12.40B	9.81B	15.37B	14.75B	15.78B	13.69B
Gross Profit	2.21B	1.81B	4.71B	4.67B	4.62B	3.86B
EBITDA	1.18B	713.40M	106.12M	642.63M	826.89M	955.19M
Net Income	573.10M	231.20M	-836.00M	-383.96M	-87.70M	68.26M
Balance Sheet
Total Assets	0	11.17B	14.98B	14.90B	14.81B	14.03B
Cash, Cash Equivalents and Short-Term Investments	104.61M	180.20M	109.60M	141.07M	308.20M	314.68M
Total Debt	0	2.91B	5.95B	5.09B	5.10B	4.75B
Total Liabilities	-5.73B	5.44B	9.88B	8.73B	8.74B	8.01B
Stockholders Equity	5.73B	5.73B	5.21B	6.01B	6.05B	5.98B
Cash Flow
Free Cash Flow	-249.90M	-118.40M	-800.10M	-432.20M	-317.60M	402.19M
Operating Cash Flow	77.10M	470.70M	202.80M	375.70M	257.20M	830.76M
Investing Cash Flow	-242.20M	-157.40M	-648.70M	-503.50M	-249.80M	-431.08M
Financing Cash Flow	571.80M	-250.10M	414.60M	51.40M	34.49M	-530.48M

Kanoria Chemicals & Industries Ltd Technical Analysis

Technical Analysis SentimentNegative

Last Price172.45

Price Trends

50DMA175.02Negative

100DMA158.59Positive

200DMA118.41Positive

Market Momentum

MACD-2.90Positive

RSI44.28Neutral

STOCH28.26Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For IN:KANORICHEM, the sentiment is Negative. The current price of 172.45 is below the 20-day moving average (MA) of 172.50, below the 50-day MA of 175.02, and above the 200-day MA of 118.41, indicating a neutral trend. The MACD of -2.90 indicates Positive momentum. The RSI at 44.28 is Neutral, neither overbought nor oversold. The STOCH value of 28.26 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for IN:KANORICHEM.

Kanoria Chemicals & Industries Ltd Peers Comparison

Overall Rating

UnderperformOutperform

Sector (55)

Financial Indicators

IN:KANORICHEM against its peers
Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
IN:AMNPLST	69Neutral	INR 8.23B	20.63	―	0.34%	-12.40%	-3.04%
IN:VALIANTORG	63Neutral	INR 9.65B	18.64	―	―	1.41%	946.41%
IN:INDOAMIN	62Neutral	INR 8.42B	10.65	―	0.42%	13.23%	22.22%
IN:KANORICHEM	60Neutral	INR 7.27B	13.06	―	―	-22.78%	―
Sector *	55Neutral	$6.65B	3.83	-15.92%	6.20%	10.91%	7.18%
IN:DEEPAKNTR	55Neutral	INR 210.17B	20.40	―	0.47%	25.13%	99.89%
IN:DIAMINESQ	43Neutral	INR 2.35B	-28.15	―	0.43%	-27.77%	-61.55%

* General Sector Average

Performance Comparison

IN:KANORICHEM and its peers over the selected period
Ticker	Company Name	Price	Change	% Change
IN:KANORICHEM	Kanoria Chemicals & Industries Ltd	172.45	95.76	124.87%
IN:AMNPLST	Amines & Plasticizers Ltd.	150.20	-52.79	-26.01%
IN:DEEPAKNTR	Deepak Nitrite Limited	1589.05	-124.92	-7.29%
IN:DIAMINESQ	Diamines & Chemicals Ltd.	229.95	-54.15	-19.06%
IN:INDOAMIN	Indo Amines Limited	118.40	-14.66	-11.02%
IN:VALIANTORG	Valiant Organics Limited	360.60	69.75	23.98%

Kanoria Chemicals & Industries Ltd Corporate Events

Kanoria Chemicals Publishes Unaudited Q1 FY2026 Results Across Public Channels

Aug 12, 2026

Kanoria Chemicals & Industries Ltd has announced that its Board of Directors approved the unaudited standalone and consolidated financial results for the quarter ended 30 June 2026 at a meeting held on 11 August 2026. The company subsequently publish...

Glossary

BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.

Date of analysis: Sep 11, 2026

Kanoria Chemicals & Industries Ltd AI Stock Analysis